β-地中海贫血(简称茁-地贫)是一种慢性遗传性溶血性贫血。在国外多发生在地中海沿岸、中东地区和东南亚各国。我国以华南和西南地区多见,发病率高达0.66%。茁-地贫对人类健康危害很大。目前对本病的治疗尚存在一定困难。高量输血加去铁治疗在发达国家取得了成功的经验,但长期 β-thalassemia (referred to as Zhuo - thalassemia) is a chronic hereditary hemolytic anemia. Occurred in many foreign countries in the Mediterranean coast, the Middle East and Southeast Asian countries. China is more common in South China and Southwest China, the incidence rate is as high as 0.66%. Zhuo - thalassemia great harm to human health. The current treatment of the disease there are still some difficulties. High blood transfusion plus iron therapy has achieved successful experience in developed countries, but long-term